Top Markets
Coin of the day
Dong Sung Bio Pharm.Co.,Ltd. Dong Sung Bio Pharm.Co.,Ltd.

Dong Sung Bio Pharm.Co.,Ltd.

002210
Peringkat dalam Saham #28327
Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations... Dong Sung Bio Pharm.Co.,Ltd. is a South Korean company with diverse operations spanning pharmaceuticals, cosmetics, hair dye manufacturing, and photodynamic therapy. Its extensive product range includes a broad selection of over-the-counter (OTC) medications designed to treat a variety of conditions. These encompass liver ailments, menopausal symptoms, skin disorders, obesity, digestive and gum health issues, and hair loss. The company's OTC offerings also feature remedies for fever, pain, inflammation, respiratory illnesses, scar reduction, and sleep disturbances, along with antiviral, anti-diarrhea, anti-nausea, blood circulation enhancing, antifungal, and antihistamine drugs. Supplementary OTC products include keratin softeners, eye nutrition supplements, and essential vitamins. Furthermore, Dong Sung Bio Pharm produces ethical (prescription-only, or ETC) drugs. These target specific medical areas such as endocrine, gastrointestinal, circulatory, neuropsychological, and oncological conditions. Its ETC portfolio also contains analgesic and anti-inflammatory agents, dermato-urinary treatments, antiviral, antibiotic, antifungal, and antihistamine medications, as well as respiratory drugs, steroids, and ophthalmic drops. Beyond its pharmaceutical lines, the company offers a range of consumer health and personal care items. These include hair coloring products, functional health foods, medical devices, various daily necessities, muscle taping supplies, disinfectants, toothpastes, shampoos for anti-hair loss and hair growth, and sanitary pads. Dong Sung Bio Pharm.Co.,Ltd. was founded in 1957 and maintains its headquarters in Seoul, South Korea.
Harga Saham
$1.11
Kapitalisasi Pasar
$27.17M
Perubahan (1 hari)
0.19%
Perubahan (1 tahun)
58.22%
Negara
KR
Perdagangan Dong Sung Bio Pharm.Co.,Ltd. (002210)

Kategori

Rasio P/E untuk Dong Sung Bio Pharm.Co.,Ltd. (002210)
Rasio P/E per August 2026 TTM: -1.67
Menurut laporan keuangan dan harga saham terbaru dari Dong Sung Bio Pharm.Co.,Ltd., rasio P/E saat ini (TTM) adalah -1.67. Pada akhir 2023, perusahaan memiliki rasio P/E sebesar -65.05.
Riwayat rasio P/E untuk Dong Sung Bio Pharm.Co.,Ltd. dari 2007 hingga 2026
Rasio P/E di akhir setiap tahun
Tahun Rasio P/E Mengubah
2026 (TTM) -1.67 -88.54%
2024 -14.60 -77.56%
2023 -65.05 -10.45%
2022 -72.64 59.95%
2021 -45.42 118.82%
2020 -20.75 -52.99%
2019 -44.15 -19.66%
2018 -54.95 -89.47%
2017 -522.00 938.94%
2016 -50.24 -123.39%
2015 214.78 -3,062.68%
2014 -7.25 -76.30%
2013 -30.59 -241.97%
2012 21.55 46.70%
2011 14.69 -561.04%
2010 -3.19 -106.83%
2009 46.61 679.47%
2008 5.98 -56.34%
2007 13.70 0.00%
Rasio P/E untuk perusahaan serupa atau pesaing
Bagaimana cara membaca P/E ratio?

Rasio Harga/Laba (P/E) mengukur hubungan antara harga saham perusahaan dan laba per sahamnya.
P/E yang rendah namun positif menunjukkan perusahaan dengan laba tinggi dibandingkan valuasinya saat ini dan mungkin dianggap undervalued. P/E negatif tinggi (mendekati 0) menunjukkan perusahaan yang mengalami kerugian besar.

Perusahaan dengan P/E di atas 30 atau negatif umumnya dianggap sebagai "saham pertumbuhan", artinya investor mengharapkan pertumbuhan atau keuntungan di masa depan.

Perusahaan dengan P/E positif di bawah 10 dianggap sebagai "saham bernilai", artinya perusahaan sudah sangat menguntungkan dan pertumbuhannya kemungkinan tidak besar.